SENATE DOCKET, NO. 635 FILED ON: 1/19/2011
SENATE . . . . . . . . . . . . . . No. 468
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Bruce E. Tarr
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act to improve health care for rheumatologic patients in the commonwealth..
_______________
PETITION OF:
Name: | District/Address: |
Bruce E. Tarr |
|
SENATE DOCKET, NO. 635 FILED ON: 1/19/2011
SENATE . . . . . . . . . . . . . . No. 468
By Mr. Tarr, a petition (accompanied by bill, Senate, No. 468) of Bruce E. Tarr for legislation to improve health care for rheumatologic patients in the Commonwealth. Financial Services. |
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE SENATE, NO. 511 OF 2009-2010.]
The Commonwealth of Massachusetts
_______________
In the Year Two Thousand Eleven
_______________
An Act to improve health care for rheumatologic patients in the commonwealth..
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. Section 47T of Chapter 175 of the General Laws is hereby amended by adding the following additional new section:
Section 47U: The commissioner shall establish an advisory panel of five medical experts to advise the commissioner on whether off-label uses for rheumatologic disease treatment not included in any of the standard reference compendia or in the medical literature are medically appropriate. The panel shall advise the commissioner whenever a dispute about coverage of such off-label prescription drugs prescribed by a physician is brought to the commissioner. All members of the advisory panel shall have significant expertise in treating rheumatologic disease, and the panel shall include at least one physician representing commercial insurers.
After consulting with said advisory panel, the commissioner may direct an insurer to make payments required by section forty-seven O of chapter one hundred and seventy-five, section eight P of chapter one hundred and seventy-six A, section four O of chapter one hundred and seventy-six B, and section four F of chapter one hundred and seventy-six G.
SECTION 2. Section 47K of Chapter 175 of the General Laws is hereby amended by adding after the phrase “treatment of cancer” in the first, fourth, and eighth paragraphs the words “or rheumatologic disease”.